Gene · 6590
Papers3,867
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,867
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Primary cutaneous, epidermotropic mycosis fungoides-like presentation: critical appraisal and description of two novel cases, broadening the spectrum of ALK+ T-cell lymphoma. | Virchows Arch | 2024 | 38780617 | PubTator, text mining | PubMed |
| A retrospective, descriptive analysis identifying non‑small cell lung cancer molecular markers. | Mol Clin Oncol | 2024 | 38756870 | PubTator, text mining | PubMed |
| Availability of Receptors for Advanced Glycation End-Products (RAGE) Influences Differential Transcriptome Expression in Lungs from Mice Exposed to Chronic Secondhand Smoke (SHS). | Int J Mol Sci | 2024 | 38732159 | PubTator, text mining | PubMed |
| Case report: Systemic presentation of ALK-positive Histiocytosis. | Front Oncol | 2024 | 38706599 | PubTator, text mining | PubMed |
| Levels of Lysozyme and SLPI in Bronchoalveolar Lavage: Exploring Their Role in Interstitial Lung Disease. | Int J Mol Sci | 2024 | 38673881 | PubTator, text mining | PubMed |
| Drug repositioning for immunotherapy in breast cancer using single-cell analysis. | NPJ Syst Biol Appl | 2024 | 38589404 | PubTator, text mining | PubMed |
| A benchmarked, high-efficiency prime editing platform for multiplexed dropout screening. | bioRxiv | 2024 | 38585933 | PubTator, text mining | PubMed |
| Machine Learning Aided Design and Optimization of Thermal Metamaterials. | Chem Rev | 2024 | 38546632 | PubTator, text mining | PubMed |
| A Diagnostic Dilemma and Classification Conundrum: Atypical Histiocytic Neoplasm Presenting as a Calvarial Mass. | Cureus | 2024 | 38529420 | PubTator, text mining | PubMed |
| Identification of prognostic biomarkers of smoking-related lung cancer. | J Thorac Dis | 2024 | 38505085 | PubTator, text mining | PubMed |
| Synthesis of secretory leukocyte protease inhibitor using cell-free protein synthesis system. | Odontology | 2024 | 38502469 | PubTator, text mining | PubMed |
| Secretory leukocyte protease inhibitor as a novel predictive biomarker in patients with diabetic kidney disease. | Front Endocrinol (Lausanne) | 2024 | 38501106 | PubTator, text mining | PubMed |
| Genetic correlations, shared risk genes and immunity landscapes between COVID-19 and venous thromboembolism: evidence from GWAS and bulk transcriptome data. | Inflamm Res | 2024 | 38433131 | PubTator, text mining | PubMed |
| Identification of claudin-2 as a promising biomarker for early diagnosis of pre-diabetes. | Front Pharmacol | 2024 | 38425650 | PubTator, text mining | PubMed |
| Granulation tissue-like spindle cell (sarcomatoid) carcinoma of the head and neck: a deceptively bland-looking underdiagnosed malignancy. | Virchows Arch | 2024 | 38403668 | PubTator, text mining | PubMed |
| Identifying functional subtypes of IgA nephropathy based on three machine learning algorithms and WGCNA. | BMC Med Genomics | 2024 | 38395835 | PubTator, text mining | PubMed |
| Inflammatory myofibroblastic tumor of the bladder turn malignant: A case report. | Int J Surg Case Rep | 2024 | 38382144 | PubTator, text mining | PubMed |
| Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances. | J Clin Invest | 2024 | 38357927 | PubTator, text mining | PubMed |
| Molecular analysis of endobronchial ultrasound needle aspirates in patients with non-small cell lung cancer: Results from the SCOPE database. | Cytopathology | 2024 | 38349229 | PubTator, text mining | PubMed |
| The secretory leukocyte protease inhibitor (SLPI) in pathophysiology of non-communicable diseases: Evidence from experimental studies to clinical applications. | Heliyon | 2024 | 38312697 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6590/papers?page=9